Literature DB >> 2904450

L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH.

S R Newcom1, M E Kadin, A A Ansari, V Diehl.   

Abstract

Nodular sclerosing Hodgkin's disease is characterized by dense collagen fibrosis. Although transforming growth factor-beta (TGF-beta) is an important bifunctional growth factor for fibroblasts and is stored and released by many cells, it requires acidification to pH 2.0-3.0 before it becomes a biologically active growth factor. We show here that the L-428 Hodgkin's cell releases a high molecular weight TGF that competes for the TGF-beta cell membrane receptor but not the TGF-alpha receptor. This growth factor is most active at physiologic pH and is 97% inactivated by acidification. Hodgkin's TGF is also inactivated by proteases and can be preserved by protease inhibitors. The Hodgkin's TGF can be separated from an autocrine growth factor using either column chromatography or electroelution from gels and is shown to have a molecular weight of approximately 350,000. Incubation of the Hodgkin's TGF in SDS releases a 25,000-D protein with reduced biological activity but which cross-reacts with anti-TGF-beta IgG. We propose that L-428 nodular sclerosing Hodgkin's disease fibrosis is mediated by a potent high molecular weight TGF-beta which, unlike TGF-beta characterized to date, is secreted in a form most active at physiologic pH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904450      PMCID: PMC442772          DOI: 10.1172/JCI113810

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

2.  Serum contains a platelet-derived transforming growth factor.

Authors:  C B Childs; J A Proper; R F Tucker; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

3.  The pathology and nomenclature of Hodgkin's disease.

Authors:  R J Lukes; J J Butler
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

4.  Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction.

Authors:  A B Roberts; L C Lamb; D L Newton; M B Sporn; J E De Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

5.  Characteristics of Hodgkin's disease-derived cell lines.

Authors:  V Diehl; H H Kirchner; H Burrichter; H Stein; C Fonatsch; J Gerdes; M Schaadt; W Heit; B Uchanska-Ziegler; A Ziegler; F Heintz; K Sueno
Journal:  Cancer Treat Rep       Date:  1982-04

6.  Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.

Authors:  C Liu; M S Tsao; J W Grisham
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

7.  Two neoplastic cell lines with unique features derived from Hodgkin's disease.

Authors:  M Schaadt; V Diehl; H Stein; C Fonatsch; H H Kirchner
Journal:  Int J Cancer       Date:  1980-12-15       Impact factor: 7.396

8.  Transforming growth factors from neoplastic and nonneoplastic tissues.

Authors:  A B Roberts; C A Frolik; M A Anzano; M B Sporn
Journal:  Fed Proc       Date:  1983-06

9.  Potentiation of fibroblast growth by nodular sclerosing Hodgkin's disease cell cultures.

Authors:  S R Newcom; L O'Rourke
Journal:  Blood       Date:  1982-07       Impact factor: 22.113

10.  Transforming growth factor production by chemically transformed cells.

Authors:  H L Moses; E L Branum; J A Proper; R A Robinson
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

View more
  13 in total

1.  Nucleoli and AgNORs in Hodgkin's disease.

Authors:  N N Mamaev; N V Medvedeva; V F Shust; A B Markochev; N D Pasternak
Journal:  Mol Pathol       Date:  1997-06

2.  Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease.

Authors:  H D Foss; M Hummel; S Gottstein; K Ziemann; B Falini; H Herbst; H Stein
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

3.  Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease.

Authors:  C Kretschmer; D B Jones; K Morrison; C Schlüter; W Feist; A J Ulmer; J Arnoldi; J Matthes; T Diamantstein; H D Flad
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

4.  Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.

Authors:  H Fahmi; C Cochet; Z Hmama; P Opolon; I Joab
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.

Authors:  Maher K Gandhi; Guido Moll; Corey Smith; Ujjwal Dua; Eleanore Lambley; Olivier Ramuz; Devinder Gill; Paula Marlton; John F Seymour; Rajiv Khanna
Journal:  Blood       Date:  2007-04-16       Impact factor: 22.113

6.  Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.

Authors:  M E Kadin; B A Agnarsson; L R Ellingsworth; S R Newcom
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

7.  Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth.

Authors:  H Merz; A Fliedner; K Orscheschek; T Binder; W Sebald; H K Müller-Hermelink; A C Feller
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

8.  Partial characterization of glioma-derived growth factor 2: a novel mitogenic activity from human cell line D-54 MG.

Authors:  E Lyon; G Y Gillespie
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

9.  Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease.

Authors:  M Kadin; J Butmarc; A Elovic; D Wong
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

10.  Neutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta.

Authors:  S R Newcom; K K Tagra; M E Kadin
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.